TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study.
Junli XueLiqiong XueWenbo TangXiaoxiao GeWei ZhaoQun LiWei PengCongqi DaiYe GuoJin LiPublished in: Therapeutic advances in medical oncology (2024)
NCT03460457.
Keyphrases